The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment
Juan‐Manuel Sancho(Hospital Universitari Germans Trias i Pujol), Josep‐María Ribera(Universitat Autònoma de Barcelona), Rubén Fernández-Álvarez(Hospital Universitario De Cabueñes), Santiago Mercadal(Huntsman Cancer Institute), Eva Domingo‐Doménech, Alberto Fernández-de-Sevilla(Duran i Reynals Hospital), Helena Pomares(Duran i Reynals Hospital), Eva González‐Barca(Institut Català d'Oncologia), Cristina Motlló(Hospital Universitari Germans Trias i Pujol), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Gustavo Tapia(Hospital Universitari Germans Trias i Pujol), Esther González-García(Hospital Universitario De Cabueñes), Miriam Moreno(Universitat Autònoma de Barcelona), Marc Sorigué(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Olga García(Universitat Autònoma de Barcelona), Evarist Feliú(Universitat Autònoma de Barcelona)
Cited by 19
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2016|457